RxDoctor Payments DataLook up a doctor →

Isaac Dor, MD

Cardiovascular Disease · Gurnee, ILNPI 1982718409

Payments from drug & device makers

$406,733in general payments, 2019–2025

Across 613 payments — averaging $663.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akcea Therapeutics, Inc.$96K
  • Novo Nordisk AS$89K
  • Kowa Research Institute, Inc.$70K
  • Boehringer Ingelheim$55K
  • United Therapeutics Corporation$49K
  • Novartis$13K
  • plus $35K from 36 others
$6,106in research payments, 2019–2025

Across 6 payments — averaging $1017.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amryt Pharma Holdings Ltd$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$406,733 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.

See all cardiovascular disease providers in Illinois

Medicare billing

Part B allowed, 2024
$1,233,909
Medicare patients
2,415
Services billed
7,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Gurnee

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →